Beta Fulltext view is in preview — article structure may vary. Browse all articles
Contents
Haematology International Journal Research Article 28 min read

Neutrophil Responses in Gestational Diabetes: A Cellular Ballet

Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu*
* Corresponding author
ISSN: 2578-501X  10.23880/hij-16000230  Received: January 26, 2024  Published: February 09, 2024
 — views
 91 references
PDF
Keywords
Gestational diabetes mellitus Neutrophil Cellular ballet Oxidative stress Inflammation Maternal immune system
Abstract

Gestational diabetes mellitus (GDM) introduces distinctive challenges to the maternal immune system, orchestrating a complex interplay with the pivotal cellular dancers, neutrophils. This review delves into the dynamic world of neutrophil responses during gestational diabetes, portraying a cellular ballet influenced by factors such as oxidative stress, cytokine modulation, and their repercussions on both maternal and fetal health. The review amalgamates existing literature to provide a nuanced understanding of the intricate dance of neutrophils in the context of gestational diabetes. The review delves into the unique cellular dynamics at the maternal-fetal interface, shedding light on how neutrophils contribute to the immune homeostasis crucial for a healthy pregnancy. The article concludes by discussing clinical implications and potential therapeutic strategies to navigate the intricate cellular ballet, offering insights for future research and intervention in the realm of gestational diabetes and immune modulation during pregnancy.

Emmanuel Ifeanyi Obeagu1* and Getrude Uzoma Obeagu2

Introduction

Gestational diabetes mellitus (GDM) emerges as a significant health concern, exerting profound influences on maternal physiology, particularly within the delicate context of pregnancy. One intriguing facet of this metabolic disorder lies in its intricate relationship with the immune system, where the cellular ballet of neutrophils takes centre stage. Neutrophils, traditionally recognized as the first responders to inflammation, embark on a nuanced dance during pregnancy, a dance that is further influenced by the presence of gestational diabetes [1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15]. The physiological landscape of gestational diabetes introduces a unique set of challenges, encompassing altered glucose metabolism, oxidative stress, and dysregulated cytokine profiles. As the primary cellular effectors of innate immunity, neutrophils navigate this altered terrain, adapting their responses to maintain immune homeostasis. Understanding the subtleties of this cellular ballet is crucial, as it unveils potential links between gestational diabetes and maternal-fetal health outcomes [16, 17, 18, 19, 20, 21, 22, 23, 24].

This review aims to unravel the intricacies of neutrophil responses in the context of gestational diabetes, shedding light on the multifaceted interactions that shape the immune landscape during pregnancy. By exploring the impact of oxidative stress, cytokine modulation, and the broader implications for both maternal and fetal health, this review seeks to provide a comprehensive overview of the dance between gestational diabetes and neutrophil behavior.

Neutrophils in Gestational Diabetes

Gestational diabetes mellitus (GDM) introduces a dynamic dimension to the behavior of neutrophils, the frontline warriors of the innate immune system. Neutrophils play a crucial role in defending the host against infections and maintaining immune homeostasis. However, in the presence of gestational diabetes, these cellular sentinels undergo alterations in their responses, contributing to the intricate cellular ballet that characterizes pregnancy [25, 26, 27, 28, 29, 30, 31, 32, 33, 34]. One of the key orchestrators of the neutrophil dance in gestational diabetes is oxidative stress. Elevated levels of glucose associated with GDM create a milieu conducive to oxidative damage. Neutrophils, sensitive to changes in redox balance, respond by undergoing activation, a process intricately linked to the generation of reactive oxygen species (ROS). This oxidative burst not only primes neutrophils for effective pathogen clearance but also contributes to the overall inflammatory milieu in gestational diabetes [35, 36, 37, 38, 39, 40, 41, 42, 43, 44]. The cytokine landscape undergoes significant shifts in gestational diabetes, influencing neutrophil behavior. Dysregulated levels of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α) contribute to an altered dance routine for neutrophils. Enhanced chemotaxis and prolonged survival of neutrophils in this inflammatory milieu may impact the resolution of inflammation and the delicate balance required for a healthy pregnancy [45, 46, 47, 48, 49].

Neutrophils, integral to maintaining maternal health, are directly affected by the metabolic disruptions seen in gestational diabetes. Aberrant neutrophil responses may contribute to an increased susceptibility to infections, delayed wound healing, and an overall compromised immune status in pregnant women with GDM [50, 51, 52, 53, 54]. The influence of altered neutrophil behavior extends beyond maternal health, potentially affecting fetal well-being. Neutrophils, while essential for maternal defense, must delicately balance their responses to avoid inadvertently impacting the developing fetus. Dysregulated neutrophil activity may contribute to inflammation at the maternal-fetal interface, with potential implications for fetal growth and development [55, 56, 57, 58, 59]. Neutrophils engage in a sophisticated dialogue at the maternal-fetal interface. In the context of gestational diabetes, this dialogue may be disrupted, impacting the delicate immunomodulation required for successful pregnancy. Understanding how neutrophils contribute to the immune homeostasis at this interface is essential for unraveling the complexities of gestational diabetes [60, 61, 62, 63, 64].

Cellular Ballet of Neutrophils

The immune choreography during gestational diabetes mellitus (GDM) unfolds as a cellular ballet, where neutrophils take centre stage in a dynamic performance at the intersection of maternal physiology and metabolic disruption. This intricate dance involves a series of coordinated movements, reflecting the adaptability of neutrophils in response to the unique challenges presented by GDM [65, 66, 67, 68, 69, 70, 71]. The opening act of the cellular ballet sees neutrophils as key players in the broader spectrum of immune cell dynamics during pregnancy. As the first responders to inflammation, neutrophils navigate the changing landscape of the maternal immune system, adapting their movements to maintain harmony in the intricate interplay of immune cells [72, 73, 74, 75, 76]. The ballet intensifies as neutrophils engage in a delicate dialogue at the maternal-fetal interface. In the presence of GDM, this conversation takes on new complexities. Neutrophils, typically involved in fostering immune homeostasis, must now navigate an altered terrain, where metabolic perturbations introduce a unique set of challenges to maintaining the delicate equilibrium essential for a healthy pregnancy [77, 78, 79, 80, 81].

The midsection of the ballet spotlights the adaptability of neutrophil function in response to the diabetic milieu. Elevated glucose levels and oxidative stress alter the choreography, influencing chemotaxis, phagocytosis, and the release of reactive oxygen species. Neutrophils, responding to this altered rhythm, play a critical role in shaping the inflammatory milieu associated with GDM.

The ballet crescendos as neutrophils engage in intricate cellular communication. Dysregulated cytokine profiles characteristic of GDM modulate the dialogue between immune cells, impacting the overall tempo of the inflammatory dance. The heightened pro-inflammatory milieu challenges neutrophils to strike a balance between effective pathogen clearance and avoiding excessive tissue damage [82, 83, 84, 85]. The finale of the cellular ballet explores the implications of neutrophil behavior for maternal and fetal health. Aberrant neutrophil responses may contribute to complications such as increased susceptibility to infections, delayed wound healing, and potential implications for fetal growth and development.

Immune Cell Dynamics in Pregnancy

Pregnancy represents a remarkable biological phenomenon where the maternal immune system undergoes dynamic changes to accommodate the developing fetus while maintaining the ability to defend against potential threats. The intricate ballet of immune cell dynamics during pregnancy is a finely tuned performance, orchestrated to ensure both maternal and fetal well-being [85]. The opening act of this immune ballet sees a shift in immune cell populations. Regulatory T cells (Tregs) and tolerogenic dendritic cells increase, fostering an environment conducive to fetal tolerance. This adaptive modulation ensures that the maternal immune system recognizes the developing fetus as self, preventing an immune response against the genetically distinct entity [86]. The ballet intensifies as innate immune cells, including macrophages and natural killer (NK) cells, engage in crosstalk with adaptive immune cells. This dynamic interaction is crucial for maintaining a balance between defense against pathogens and tolerance to the semi-allogeneic fetus. The delicate choreography prevents excessive inflammation while preserving the ability to mount an effective immune response when needed. The midsection of the performance highlights the impact of hormonal fluctuations, particularly the rise in progesterone. Hormones play a conductor’s role, influencing immune cell behavior and modulating their responses. Progesterone, for instance, fosters an anti-inflammatory milieu, contributing to immune tolerance essential for sustaining pregnancy. The climax of the ballet unfolds at the maternal-fetal interface, where immune cells engage in a sophisticated dialogue. Trophoblast cells, acting as intermediaries, communicate with maternal immune cells to establish an immunologically privileged environment. This dialogue is crucial for preventing immune rejection of the fetal-placental unit while maintaining vigilance against potential threats.

Immunomodulation at the Maternal-Fetal Interface

The maternal-fetal interface, a dynamic and complex environment, is the epicenter where the maternal immune system and the developing fetus intricately interact. This ballet of immunomodulation is essential for the successful progression of pregnancy, striking a delicate balance between tolerance to the semi-allogeneic fetus and the ability to respond to potential threats [87]. The overture of this performance involves trophoblast cells, the architects of the placenta, engaging in a sophisticated dialogue with maternal immune cells. Trophoblasts, equipped with unique surface markers and immunomodulatory molecules, communicate with uterine natural killer (uNK) cells, macrophages, and T cells, establishing an environment that fosters immune tolerance and prevents rejection of the fetal-placental unit [87]. As the ballet unfolds, the process of decidualization transforms the endometrium into the decidua, creating a specialized microenvironment. Tolerogenic dendritic cells, abundant in the decidua, play a pivotal role in presenting fetal antigens to maternal T cells in a manner that promotes regulatory T cell (Treg) expansion. This promotes an anti-inflammatory milieu conducive to fetal tolerance [87]. The midsection of the ballet is marked by hormonal influences, where progesterone and estrogen orchestrate immunomodulatory effects. Progesterone, in particular, contributes to the expansion of Tregs and the suppression of pro-inflammatory responses, maintaining an immune balance essential for successful implantation and fetal development. The ballet crescendos with the dynamic modulation of the cytokine milieu. Interleukin-10 (IL-10) and transforming growth factor-beta (TGF-β), produced by various immune cells and trophoblasts, exert immunosuppressive effects, influencing the behavior of both maternal and fetal immune cells. This orchestrated cytokine dance ensures a controlled and regulated immune environment.

Neutrophil Function in a Diabetic Milieu

The opening act of this performance explores the impact of diabetes on neutrophil chemotaxis. Elevated glucose levels influence the direction and speed of neutrophil migration, potentially affecting their ability to reach sites of infection or tissue damage. Understanding these alterations is crucial for deciphering the dynamics of the immune response in diabetic individuals [88]. The diabetic stage sets the scene for changes in neutrophil phagocytic activity and the production of reactive oxygen species (ROS). While efficient phagocytosis is essential for pathogen clearance, an imbalance in ROS production may contribute to oxidative stress and tissue damage. Examining these alterations provides insights into the delicate equilibrium between host defense and potential harm to surrounding tissues. The midsection of the review delves into the impact of diabetes on neutrophil apoptosis. Neutrophils typically undergo programmed cell death to maintain immune homeostasis. However, in a diabetic milieu, neutrophils may exhibit delayed apoptosis, leading to a prolonged lifespan. This alteration raises questions about the potential consequences, such as increased tissue damage and chronic inflammation [88]. As the diabetic narrative unfolds, the focus shifts to the implications of altered neutrophil function for chronic inflammation. Prolonged neutrophil lifespan, coupled with heightened ROS production, may contribute to a sustained inflammatory state. Understanding these implications is crucial for unraveling the link between diabetes and the increased risk of inflammatory complications.

Clinical Implications

Altered chemotaxis and impaired phagocytosis in diabetic individuals may elevate the risk of infections. Clinicians should be vigilant, considering the potential for delayed or ineffective immune responses to microbial threats. Monitoring and preventive measures, such as vaccination, become crucial in managing the increased susceptibility to infections [89]. The prolonged lifespan of neutrophils and potential hyperactivity of ROS production may contribute to delayed wound healing in diabetic patients. Clinically, this implies a need for meticulous wound care, early detection of infections, and interventions aimed at promoting efficient tissue repair to prevent complications such as ulcers and chronic wounds. The sustained inflammatory state resulting from altered neutrophil function may contribute to cardiovascular complications in diabetes. Clinicians should recognize the link between chronic inflammation and cardiovascular risk, emphasizing the importance of managing inflammation alongside glycemic control to reduce the long-term impact on the vascular system.

In diabetic individuals, the dysregulated neutrophil response may predispose them to acute exacerbations of inflammatory conditions. Clinicians should consider this heightened inflammatory state when managing comorbidities, such as respiratory or joint-related conditions, to prevent severe complications and improve overall outcomes [89]. The concept of metabolic memory, wherein epigenetic modifications persist despite glycemic control, highlights the importance of early intervention in diabetes management. Clinicians should adopt a holistic approach, addressing not only current glycemic levels but also strategies to mitigate the long-lasting impact of altered neutrophil function on immune memory. Recognizing the heterogeneity in neutrophil responses among individuals with diabetes underscores the need for personalized therapeutic approaches. Tailoring interventions based on the specific immunophenotype of each patient may optimize treatment outcomes and reduce the risk of complications associated with altered neutrophil function.

Pregnancy Complications and Neutrophil Dysfunction

Neutrophil dysfunction may contribute to the pathophysiology of preterm birth. Altered chemotaxis, impaired phagocytosis, or excessive inflammation may disrupt the delicate balance required for maintaining a healthy pregnancy duration. Investigating these neutrophil-related factors may provide insights into the mechanisms underlying preterm labor [90]. Preeclampsia, a hypertensive disorder of pregnancy, is characterized by immune dysregulation. Neutrophil dysfunction, including altered adhesion, may contribute to the endothelial damage seen in preeclampsia. Unraveling the specific neutrophil-related mechanisms may enhance our understanding of the immune pathways involved in this complex disorder. Gestational diabetes mellitus (GDM) introduces alterations in neutrophil function due to the diabetic milieu. The resulting inflammatory environment may contribute to complications such as gestational hypertension and increased susceptibility to infections. Exploring the links between neutrophil dysfunction and the development of GDM-related complications is crucial for comprehensive pregnancy management [90].

Neutrophil dysfunction may play a role in the development of intrauterine growth restriction. Impaired neutrophil responses could contribute to placental insufficiency, limiting fetal nutrient supply. Investigating the specific neutrophil- related factors involved in IUGR could open avenues for targeted interventions to improve fetal growth. Neutrophil dysfunction may contribute to recurrent pregnancy loss through mechanisms such as impaired clearance of apoptotic cells or dysregulated immune responses at the maternal-fetal interface. Examining these neutrophil-related factors may provide insights into the immune processes that influence the recurrence of pregnancy loss [91]. Neutrophil dysfunction increases the susceptibility to infections during pregnancy. This heightened vulnerability may contribute to complications such as chorioamnionitis or postpartum infections. Understanding the specific neutrophil-related factors that compromise the maternal immune response is crucial for preventing and managing infectious complications.

Therapeutic Approaches to Modulate Neutrophil Responses

Utilizing anti-inflammatory agents represents a foundational approach to modulating neutrophil responses. Nonsteroidal anti-inflammatory drugs (NSAIDs) or corticosteroids can be employed to dampen excessive inflammation, mitigating the potential tissue damage caused by hyperactive neutrophils. Careful consideration of the specific inflammatory pathways involved is essential to tailor treatment regimens effectively. Given the role of oxidative stress in influencing neutrophil behavior, antioxidant therapy presents a compelling avenue. Antioxidants, such as vitamins C and E, may counteract the damaging effects of reactive oxygen species (ROS). This approach is particularly relevant in conditions where oxidative stress contributes to neutrophil dysfunction, such as in diabetic complications [91]. Biologic agents targeting specific immune pathways offer a precision-based strategy for modulating neutrophil responses. Monoclonal antibodies or other biologics directed against pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) or interleukin-1 (IL-1), can be employed to interrupt the inflammatory cascade and regulate neutrophil activity.

G-CSF therapy represents an approach to enhance neutrophil production and function. In conditions characterized by neutropenia or impaired neutrophil mobilization, such as chemotherapy-induced myelosuppression, G-CSF administration can stimulate the bone marrow to produce and release mature neutrophils, bolstering the immune response. Targeting specific receptors or signaling pathways involved in neutrophil activation provides opportunities for pharmacological modulation. Small molecules, such as tyrosine kinase inhibitors or chemokine receptor antagonists, can be explored to regulate neutrophil chemotaxis and activation in a more targeted manner [91]. Lifestyle modifications, including diet and exercise, can influence systemic inflammation and, consequently, neutrophil responses. Dietary components with anti-inflammatory properties, such as omega-3 fatty acids, may modulate neutrophil function. Regular physical activity also exerts anti-inflammatory effects, potentially impacting neutrophil behavior. Stem cell therapy offers a regenerative approach to modulating immune responses, including those of neutrophils. Mesenchymal stem cells, for example, have been investigated for their immunomodulatory properties, which may help restore balance to dysregulated neutrophil function in conditions like autoimmune diseases. Advancements in precision medicine allow for tailoring therapeutic interventions based on individual patient profiles. Understanding the specific molecular mechanisms driving neutrophil dysfunction enables the development of personalized treatment strategies, optimizing efficacy while minimizing potential side effects.

Recommendations

Encourage and support ongoing research endeavors to deepen our understanding of how neutrophil dysfunction contributes to pregnancy complications such as preterm birth, preeclampsia, and gestational diabetes. This includes investigating specific molecular pathways and potential biomarkers associated with adverse outcomes. Advocate for and facilitate the initiation of clinical trials focusing on neutrophil-targeted therapies. These trials should explore the efficacy and safety of interventions aimed at modulating neutrophil responses in conditions such as diabetes, pregnancy complications, and other neutrophil-associated disorders. Invest in research and development of precision medicine approaches for managing conditions linked to neutrophil dysfunction. This includes identifying patient- specific profiles related to neutrophil behavior and tailoring therapeutic strategies accordingly to enhance treatment efficacy and reduce potential side effects.

Promote public health initiatives focused on diabetes prevention and management. These initiatives should include education on lifestyle modifications, early detection, and intervention strategies to prevent the development of diabetes-related complications, considering the role of neutrophil dysfunction in these complications. Encourage the integration of immunomodulatory strategies, such as anti- inflammatory agents, antioxidant therapy, and biologics, into clinical practice. Develop guidelines and recommendations for healthcare professionals to consider these approaches in the management of diseases where neutrophil dysfunction plays a significant role. Foster interdisciplinary collaboration between obstetrics, immunology, and endocrinology fields to promote a comprehensive understanding of neutrophil dynamics in pregnancy and metabolic disorders. Joint efforts can lead to innovative research projects, shared resources, and a holistic approach to patient care.

Launch education and awareness campaigns aimed at healthcare professionals and the general public. Enhance understanding of the role of neutrophils in health and disease, emphasizing the importance of early intervention, lifestyle modifications, and adherence to treatment plans in conditions where neutrophil dysfunction is implicated. Provide support for stem cell research focused on understanding the immunomodulatory properties of stem cells, especially mesenchymal stem cells. Explore the potential of stem cell therapies in modulating neutrophil responses and regenerating immune function in conditions where neutrophil dysfunction contributes to pathology. Advocate for the incorporation of neutrophil assessments into routine clinical practice, especially in conditions prone to neutrophil dysfunction. Develop standardized protocols for assessing neutrophil function and tailor treatment plans based on individual patients’ immune profiles. Encourage global collaboration and data sharing to accelerate progress in the field of neutrophil research. Facilitate the exchange of knowledge, research findings, and clinical insights to ensure a collective effort in addressing the challenges associated with neutrophil dysfunction in diverse populations.

Conclusion

In the intricate symphony of the immune system, neutrophils emerge as pivotal players, orchestrating a dynamic dance that influences health and disease. This review has navigated through the diverse realms where neutrophils play a central role, exploring their behavior in the context of pregnancy, diabetes, and various pathological conditions. The understanding of neutrophil responses has evolved beyond mere sentinels of infection to intricate choreographers of immune dynamics. From the delicate maternal-fetal interface during pregnancy to the dysregulated terrain of diabetes, neutrophils adapt their choreography, influencing the balance between immune defense and potential harm. Dysfunction in neutrophil behavior has been unveiled as a common thread in complications such as preterm birth, preeclampsia, and gestational diabetes. These revelations offer opportunities for targeted therapeutic interventions to enhance pregnancy outcomes and maternal-fetal well-being.

In diabetes, the altered neutrophil dance reflects a symphony of oxidative stress, cytokine modulation, and metabolic memory. Unraveling these intricacies provides insights into the link between diabetes and heightened susceptibility to infections, delayed wound healing, and chronic inflammation. Therapeutic strategies targeting neutrophil responses emerge as promising avenues, ranging from anti-inflammatory agents to precision medicine approaches tailored to individual immune profiles.

References

  1. Ifediora AC, Obeagu EI, Akahara IC, Eguzouwa UP (2016) Prevalence of Urinary Tract Infection in Diabetic Patients Attending Umuahia Health Care Facilities. J Bio Innov 5(1): 68-82.
  2. Ugwu OP, Alum EU, Okon MB, Aja PM, Obeagu EI, et al. (2023) Ethanol Root Extract and Fractions of Sphenocentrum Jollyanum Abrogate Hyperglycaemia and Low Body Weight in Streptozotocin-Induced Diabetic Wistar Albino Rats. RPS Pharmacy and Pharmacology Reports 2(2): rqad010.
  3. Obeagu EI, Obeagu GU (2018) Utilization of Antioxidants in the Management of Diabetes Mellitus Patients. J Diabetes Clin Prac. 1(1): 102.
  4. Obeagu EI, Okoroiwu IL, Obeagu GU (2016) Some Haematological Variables in Insulin Dependent Diabetes Mellitus Patients in Imo State Nigeria. Int J Curr Res Chem Pharm Sci 3(4):110-117.
  5. Nwakuilite A, Nwanjo HU, Nwosu DC, Obeagu EI (2020) Evaluation of Some Trace Elements in Streptozocin Induced Diabetic Rats Treated with Moringa Oleifera Leaf Powder. WJPMR 6(12): 15-18.
  6. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, et al. (2022) ABO Blood Groups and Gestational Diabetes Among Pregnant Women Attending University of Ilorin Teaching Hospital, Kwara State, Nigeria. International Journal of Research and Reports in Hematology 5(2): 159-167.
  7. Okafor CJ, Yusuf SA, Mahmoud SA, Salum SS, Vargas SC, et al. (2021) Effect of Gender and Risk Factors in Complications of Type 2 Diabetic Mellitus among Patients Attending Diabetic Clinic in Mnazi Mmoja Hospital, Zanzibar. Journal of Pharmaceutical Research International 33(29B): 67-78.
  8. Galano ES, Yusuf SA, Ogbonnia SO, Ogundahunsi OA, Obeagu EI, et al. (2021) Effect of Extracts of Kigelia Africana Fruit and Sorghum Bicolor Stalk on the Biochemical Parameters of Alloxan-Induced Diabetic Rats. Journal of Pharmaceutical Research International 33(25B):86-97.
  9. Kama SC, Obeagu EI, Alo MN, Ochei KC, Ezugwu UM, et al. (2020) Incidence of Urinary Tract Infection among Diabetic Patients in Abakaliki Metropolis. Journal of Pharmaceutical Research International 32(28): 117- 121.
  10. Nwakulite A, Obeagu EI, Eze R, Vincent CC, Chukwurah EF, et al. (2021) Evaluation of Catalase and Manganese in Type 2 Diabetic Patients in University of Port Harcourt Teaching Hospital. Journal of Pharmaceutical Research International 33(30B): 40-45.
  11. Obeagu EI, Agreen FC (2023) Anaemia among Pregnant Women: A Review of African Pregnant Teenagers. J Pub Health Nutri 6(1): 138.
  12. Obeagu EI, Ezimah AC, Obeagu GU (2016) Erythropoietin in the Anaemias of Pregnancy: A Review. Int J Curr Res Chem Pharm Sci 3(3): 10-18.
  13. Obeagu EI, Adepoju OJ, Okafor CJ, Obeagu GU, Ibekwe AM, et al. (2021) Assessment of Haematological Changes in Pregnant Women of Ido, Ondo State, Nigeria. J Res Med Dent Sci 9(4):145-148.
  14. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2):10-13.
  15. Jakheng SPE, Obeagu EI (2022) Seroprevalence of Human Immunodeficiency Virus Based on Demographic and Risk Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Nigeria. J Pub Health Nutri 5(6): 127.
  16. Nwakulite A, Obeagu EI, Nwanjo HU, Nwosu DC, Nnatuanya IN, et al. (2021) Studies on Pancreatic Gene Expression in Diabetic Rats Treated with Moringa Oleifera Leaf. Journal of Pharmaceutical Research International 33(28A): 78-86.
  17. Nwosu DC, Nwanjo HU, Obeagu EI, Ugwu GU, Ofor IB, et al. (2015) Evaluation of Lipoprotein a and Lipid Tetrad Index Pattern in Diabetic Patients Attending Metabolic Clinic in the Federal Medical Centre, Owerri, Imo State. World Journal of Pharmacy and Pharmaceutical Sciences 4(3): 126-140.
  18. Ezema GO, Omeh NY, Egbachukwu S, Agbo EC, Ikeyi AP, et al. (2023) Evaluation of Biochemical Parameters of Patients with Type 2 Diabetes Mellitus Based on Age and Gender in Umuahia. Asian Journal of Dental and Health Sciences 3(2):32-36.
  19. Adu ME, Chukwuani U, Ezeoru V, Okafor CJ, Amaechi CO, et al. (2021) Studies on Molecular Docking of Moringa Oleifera Leaf Phytochemical Constituents on Alpha Glucosidase, Alpha Amylase and Dipeptidyl Peptidase. Journal of Pharmaceutical Research International 33(28A): 239-245.
  20. Ezugwu UM, Onyenekwe CC, Ukibe NR, Ahaneku JE, Obeagu EI (2021) Plasma Level of Macromolecules and Mathematical Calculation of Potential Energy in Type 2 Diabetic Individuals at NAUTH, Nnewi, Nigeria. Journal of Pharmaceutical Research International 33(47B): 242- 248.
  21. Obeagu EI, Obeagu GU, Chukwueze CM, Ikpenwa JN, Ramos GF (2022) Evaluation of Protein C, Protein S and Fibrinogen of Pregnant Women with Malaria in Owerri Metropolis. Madonna University journal of Medicine and Health Sciences 2(2): 1-9.
  22. Obeagu EI, Obeagu GU, Adepoju OJ (2022) Evaluation of Haematological Parameters of Pregnant Women Based on Age Groups in Olorunsogo Road Area of Ido, Ondo State. J Bio Innov 11(3): 936-941.
  23. Obeagu EI (2022) An Update on Utilization of Antenatal Care among Pregnant Women in Nigeria. Int J Curr Res Chem Pharm Sci 9(9): 21-26.
  24. Okoroiwu IL, Obeagu EI, Obeagu GU (2022) Determination of Clot Retraction in Preganant Women Attending Antenatal Clinic in Federal Medical Centre Owerri, Nigeria. Madonna University Journal of Medicine and Health Sciences 2(2): 91-97.
  25. Obeagu EI, Hassan AO, Adepoju OJ, Obeagu GU, Okafor CJ (2021) Evaluation of Changes in Haematological Parameters of Pregnant Women Based on Gestational Age at Olorunsogo Road Area of Ido, Ondo State. Nigeria. Journal of Research in Medical and Dental Science 9(12): 462-464.
  26. Anyiam AF, Obeagu EI, Obi E, Omosigho PO, Irondi EA, et al. (2022) ABO Blood Groups and Gestational Diabetes among Pregnant Women Attending University of Ilorin Teaching Hospital, Kwara State, Nigeria. International Journal of Research and Reports in Hematology 5(2): 159-167.
  27. Obeagu EI (2023) Gestational Thrombocytopaenia. J Gynecol Women’s Health 25(3): 001-003.
  28. Jakheng SP, Obeagu EI, Abdullahi IO, Jakheng EW, Chukwueze CM, et al. (2022) Distribution Rate of Chlamydial Infection According to Demographic Factors among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. South Asian Journal of Research in Microbiology 13(2): 26-31.
  29. Obeagu EI, Ogbonna US, Nwachukwu AC, Ochiabuto O, Enweani IB, et al. (2021) Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  30. Nwakulite A, Obeagu EI, Eze R, Ugochi VE, Vincent CC, et al. (2021) Estimation of Serum Glutathione Peroxidase in Streptozotocin Induced Diabetic Rat Treated with Bitter Leaf Extract. Journal of Pharmaceutical Research International 33(30B): 200-206.
  31. Okoroiwu IL, Obeagu EI, Miguel HGS, Bote SA, Obeagu GU (2023) Characterisation of HLA-DR Antigen in Patients Type 1 Diabetes Mellitus in Patient Attending a Tertairy Hospital in Enugu, South-East Nigeria. Academic Journal of Health Sciences 38(1): 104-110.
  32. Okoroiwu IL, Obeagu EI, Obeagu GU, Chikezie CC, Ezema GO (2016) The Prevalence of Selected Autoimmune Diseases. Int J Adv Multidiscip Res 3(3): 9-14.
  33. Nwakuilite A, Nwanjo HU, Nwosu DC, Obeagu EI (2020) Evaluation of Enzyme Antioxidants in Streptozocin Induced Diabetic Rats Treated with Moringa Oleifera Leaf Powder. European Journal of Biomedical 7(11): 285-288.
  34. Nwosu DC, Nwanjo HU, Opara AU, Ofor IB, Obeagu EI, et al. (2015) Evaluation of C-Reactive Protein, Selenium and Glycosylated Haemoglobin Levels in Diabetic Patients Attending Metabolic Clinic in the Federal Medical Centre, Owerri, Imo State. World Journal of Pharmacy and Pharmaceutical Sciences 4 (3): 141-152.
  35. Nwakuilite A, Nwanjo HU, Nwosu DC, Obeagu EI (2021) Evaluation of Kidney Injury Molecule-1, Cystatin C, and Serum Electrolytes in Streptozocin Induced Diabetic Rats Treated with Moringa Oleifera Leaf Powder. Biochemistry & Molecular Biology Journal 7(2): 1-4.
  36. Ugwu OP, Alum EU, Okon MB, Aja PM, Obeagu EI, et al. (2023) Anti-Nutritional and Gas Chromatography- Mass Spectrometry (GC-MS) Analysis of Ethanol Root Extract and Fractions of Sphenocentrum Jollyanum. RPS Pharmacy and Pharmacology Reports 2(2): rqad007.
  37. Obeagu EI, Scott GY, Amekpor F, Ugwu OP, Alum EU (2023) Covid-19 Infection and Diabetes: A Current Issue. International Journal of Innovative and Applied Research 11(1): 25-30.
  38. Ugwu OP, Alum EU, Obeagu EI, Okon MB, Aja PM, et al. (2023) Effect of Ethanol Leaf Extract of Chromolaena Odorata on Lipid Profile of Streptozotocin Induced Diabetic Wistar Albino Rats. IAA Journal of Biological Sciences 10(1): 109-117.
  39. Ifeanyi OE (2019) Gestational Diabetes: Haematological Perspective. South Asian Research Journal of Applied Medical Sciences 1(2): 41-42.
  40. Obeagu EI, Abdirahman BF, Bunu UO, Obeagu GU (2023) Obsterics Characteristics that Effect the Newborn Outcomes. Int J Adv Res Biol Sci 10(3): 134-143.
  41. Obeagu EI, Ogunnaya FU (2023) Pregnancy-Induced Haematological Changes: A Key to Marternal and Child Health. European Journal of Biomedical 10(8): 42-43.
  42. Ezeoru VC, Enweani IB, Ochiabuto O, Nwachukwu AC, Ogbonna US, et al. (2021) Prevalence of Malaria with Anaemia and HIV Status in Women of Reproductive Age in Onitsha, Nigeria. Journal of Pharmaceutical Research International 33(4): 10-19.
  43. Okamgba OC, Nwosu DC, Nwobodo EI, Agu GC, Ozims SJ, et al. (2017) Iron Status of Pregnant and Post-Partum Women with Malaria Parasitaemia in Aba Abia State, Nigeria. Annals of Clinical and Laboratory Research 5(4): 206.
  44. Eze RI, Obeagu EI, Edet FN (2021) Frequency of Rh Antigen C and c among pregnant women in Sub-Urban Area in Eastern Nigeria. Madonna J Med Health Sci 1(1):19-30.
  45. Obeagu EI, Muhimbura E, Kagenderezo BP, Nakyeyune S, Obeagu GU (2022) An Insight of Interleukin-6 and Fibrinogen: In Regulating the Immune System. J Biomed Sci 11(10): 83.
  46. Ifeanyi OE, Vincent CC, Ugochi CM (2019) Studies on Some Cytokines of Apparently Healthy Nigerian Women Aged 10-40 Years. Int J Curr Res Med Sci 5(12): 24-30.
  47. Obeagu EI, Muhimbura E, Kagenderezo BP, Uwakwe OS, Nakyeyune S, et al. (2022) An Update on Interferon Gamma and C Reactive Proteins in Sickle Cell Anaemia Crisis. J Biomed Sci 11(10): 84.
  48. Obeagu EI, Hamisi S, Bunu UO (2023) An Update on Cytokine Storm in Covid-19 Infection: Pivotal to the Survival of the Patients. Int J Adv Res Biol Sci 10(3): 171- 180.
  49. Obeagu EI, Okoroiwu IL, Nwanjo HU, Nwosu DC (2019) Evaluation of Interferon-Gamma, Interleukin 6 and Interleukin 10 in Tuberculosis Patients in Umuahia. Ann Clin Lab Res 7(2): 307.
  50. Obeagu EI, Ofodile AC, Okwuanaso CB (2023) A review of Urinary Tract Infections in Pregnant Women: Risks Factors. J Pub Health Nutri 6(1): 137.
  51. Obeagu EI, Obeagu GU, Musiimenta E (2023) Post- Partum Haemorrhage among Pregnant Women: Update on Risks Factors. Int J Curr Res Med Sci 9(2): 14-17.
  52. Obeagu EI, Obeagu GU, Ogunnaya FU (2023) Deep Vein Thrombosis in Pregnancy: A Review of Prevalence and Risk Factors. Int J Curr Res Chem Pharm Sci 10(8): 14- 21.
  53. Jakheng SP, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(1): 222-229.
  54. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Some Haematological Parameters in Malaria Infected Pregnant Women in Imo State Nigeria. Int J Curr Res Biol Med 3(9): 1-14.
  55. Onyenweaku FC, Amah HC, Obeagu EI, Nwandikor UU, Onwuasoanya UF (2017) Prevalence of Asymptomatic Bacteriuria and its Antibiotic Susceptibility Pattern in Pregnant Women Attending Private Ante Natal Clinics in Umuahia Metropolitan. Int J Curr Res Biol Med 2(2): 13-23.
  56. Okoroiwu IL, Chinedu-Madu JU, Obeagu EI, Vincent CC, Ochiabuto OM, et al. (2021) Evaluation of Iron Status, Haemoglobin and Protein Levels of Pregnant Women in Owerri Metropolis. Journal of Pharmaceutical Research International 33(27A): 36-43.
  57. Obeagu EI, Njar VE, Obeagu GU (2023) Infertility: Prevalence and Consequences. Int J Curr Res Chem Pharm Sci 10(7): 43-50.
  58. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of Levels of Some Inflammatory Cytokines in Preeclamptic Women in Owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  59. Obeagu EI, Faduma MH, Uzoma G (2023) Ectopic Pregnancy: A Review. Int J Curr Res Chem Pharm Sci 10(4): 40-44.
  60. Obeagu EI, Gamade SM, Obeagu GU (2023) The Roles of Neutrophils in Pregnancy. Int J Curr Res Med Sci 9(5): 31-35.
  61. Eze R, Obeagu EI, Nwakulite A, Okoroiwu IL, Vincent CC, et al. (2021) Evaluation of Copper Status and Some Red Cell Parameters of Pregnant Women in Enugu State, South Eastern Nigeria. Journal of Pharmaceutical Research International 33(30A): 67-71.
  62. Obeagu EI, Obeagu GU (2023) Molar Pregnancy: Update of Prevalence and Risk Factors. Int J Curr Res Med Sci 9(7): 25-28.
  63. Obeagu EI, Bunu UO (2023) Factors that Influence Unmet Need for Family Planning. International Journal of Current Research in Biology and Medicine 8(1): 23- 27.
  64. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Barriers to Utilization of Maternal Health Services in Southern Senatorial District of Cross Rivers State, Nigeria. International Journal of Advanced Multidisciplinary Research 4(8): 1-9.
  65. Ogbu IS, Odeh EJ, Ifeanyichukwu OE, Ogbu C, Ude UA, et al. (2023) Prevalence of Prediabetes among First Degree Relatives of Type 2 Diabetes Individuals in Abakaliki, Ebonyi State Nigeria. Academic Journal of Health Sciences: Medicina Balear 38(2): 85-88.
  66. Ifeanyi OE (2018) An Update on Diabetes Mellitus. Int J Curr Res Med Sci 4(6): 71-81.
  67. Emannuel G, Martin O, Peter OS, Obeagu EI, Daniel K (2023) Factors Influencing Early Neonatal Adverse Outcomes among Women with HIV with Post Dated Pregnancies Delivering at Kampala International University Teaching Hospital, Uganda. Asian Journal of Pregnancy and Childbirth 6(1): 203-211.
  68. Okorie HM, Obeagu EI, Eze EN, Jeremiah ZA (2018) Assessment of Coagulation Parameters in Malaria Infected Pregnant Women in Imo State, Nigeria. International Journal of Current Research in Medical Sciences 4(9): 41-49.
  69. Obeagu EI, Obeagu GU (2023) Postpartum Haemorrhage among Women Delivering Through Spontaneous Vaginal Delivery: Prevalence and Risk Factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  70. Obeagu E, Eze RI, Obeagu EI, Nnatuanya IN, Dara EC (2022) Zinc Level in Apparently Pregnant Women in Urban Area. Madonna University journal of Medicine and Health Sciences ISSN: 2814-3035 2(1): 134-148.
  71. Ogomaka IA, Obeagu EI (2021) Malaria in Pregnancy Amidst Possession of Insecticide Treated Bed Nets (ITNs) in Orlu LGA of Imo State, Nigeria. Journal of Pharmaceutical Research International 33(41B): 380- 386.
  72. Obeagu EI, Ogunnaya FU, Obeagu GU, Ndidi AC (2023) Sickle Cell Anaemia: A Gestational Enigma. Migration 10: 72-75.
  73. Ifeanyi OE, Uzoma OG (2018) A Review on Erythropietin in Pregnancy. J Gynecol Womens Health 8(3): 1-4.
  74. Ifeanyi OE (2018) A Review on Pregnancy and Haematology. Int J Curr Res Biol Med 3(5): 26-28.
  75. Nwosu DC, Nwanjo HU, Obeagu EI, Ibebuike JE, Ezeama MC, et al. (2015) Changes in Liver Enzymes and Lipid Profile of Pregnant Women with Malaria in Owerri, Nigeria. International Journal of Current Research and Academic Review 3(5): 376-383.
  76. Ibebuike JE, Ojie CA, Nwokike GI, Obeagu EI, Nwosu DC, et al. (2017) Factors that Influence Women’s Utilization of Primary Health Care Services in Calabar Cros River State, Nigeria. Int J Curr Res Chem Pharm Sci 4(7): 28-33.
  77. Eze R, Ezeah GA, Obeagu EI, Omeje C, Nwakulite A (2021) Evaluation of Iron Status and Some Haematological Parameters of Pregnant Women in Enugu, South Eastern Nigeria. World Journal of Pharmaceutical and Medical Research 7(5): 251-254.
  78. Elemchukwu Q, Obeagu EI, Ochei KC (2014) Prevalence of Anaemia among Pregnant Women in Braithwaite Memorial Specialist Hospital (BMSH) Port Harcourt. IOSR Journal of Pharmacy and Biological Sciences 9(5): 59-64.
  79. Akandinda M, Obeagu EI, Katonera MT (2022) Non Governmental Organizations and Women’s Health Empowerment in Uganda: A Review. Asian Research Journal of Gynaecology and Obstetrics 5(1): 263-267.
  80. Jakheng SPE, Obeagu EI, Jakheng EW, Uwakwe OS, Eze GC, et al. (2022) Occurrence of Chlamydial Infection Based on Clinical Symptoms and Clinical History among Pregnant Women Attending Clinics in Zaria Metropolis, Kaduna State, Nigeria. International Journal of Research and Reports in Gynaecology 5(1): 222-229.
  81. Gamde MS, Obeagu EI (2023) Iron Deficiency Anaemia: Enemical to Pregnancy. European Journal of Biomedical 10(9): 272-275.
  82. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Evaluation of Levels of Some Inflammatory Cytokines in Preeclamptic Women in Owerri. Journal of Pharmaceutical Research International 33(42A): 53-65.
  83. Emeka-Obi OR, Ibeh NC, Obeagu EI, Okorie HM (2021) Studies of Some Haemostatic Variables in Preeclamptic Women in Owerri, Imo State, Nigeria. Journal of Pharmaceutical Research International 33(42B): 39-48.
  84. Obeagu EI, Obeagu GU (2023) Postpartum Haemorrhage among Women Delivering through Spontaneous Vaginal Delivery: Prevalence and Risk Factors. Int J Curr Res Chem Pharm Sci 10(8): 22-26.
  85. Obeagu EI, Obeagu GU (2023) Sickle Cell Anaemia in Pregnancy: A Review. International Research in Medical and Health Sciences 6(2): 10-13.
  86. Grayson M (2019) an Issue of Immunology and Allergy Clinics of North America In: Grayson MH (Ed.), Infections and Asthma. 1st (Edn.), Elsevier Health Sciences, pp: 298.
  87. Liu N, Shen H, Wang Z, Qin X, Li M, et al. (2023) Autophagy Inhibition in Trophoblasts Induces Aberrant Shift in CXCR4+ Decidual NK Cell Phenotype Leading to Pregnancy Loss. Journal of Clinical Medicine 12(23): 7491.
  88. Injarabian L, Devin A, Ransac S, Marteyn BS (2019) Neutrophil Metabolic Shift during Their Lifecycle: Impact on Their Survival and Activation. International journal of molecular sciences 21(1): 287.
  89. Dowey R, Iqbal A, Heller SR, Sabroe I, Prince LR (2021) A Bittersweet Response to Infection in Diabetes; Targeting Neutrophils to Modify Inflammation and Improve Host Immunity. Frontiers in Immunology 12: 678771.
  90. Cappelletti M, Bella SD, Ferrazzi E, Mavilio D, Divanovic S (2016) Inflammation and preterm birth. Journal of Leucocyte Biology 99(1): 67-78.
  91. Kumar S, Saxena J, Srivastava VK, Kaushik S, Singh H, et al. (2022) The Interplay of Oxidative Stress and ROS Scavenging: Antioxidants as a Therapeutic Potential in Sepsis. Vaccines (Basel) 10(10): 1575.
More from this journal

Cite this article

BibTeX
APA
RIS
@article{emmanuel2024,
  title   = {Neutrophil Responses in Gestational Diabetes: A Cellular Ballet},
  author  = {Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu},
  journal = {Haematology International Journal},
  year    = {2024},
  volume  = {8},
  number  = {1},
  doi     = {10.23880/hij-16000230}
}
Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu (2024). Neutrophil Responses in Gestational Diabetes: A Cellular Ballet. Haematology International Journal, 8(1). https://doi.org/10.23880/hij-16000230
TY  - JOUR
TI  - Neutrophil Responses in Gestational Diabetes: A Cellular Ballet
AU  - Emmanuel Ifeanyi Obeagu* and Getrude Uzoma Obeagu
JO  - Haematology International Journal
PY  - 2024
VL  - 8
IS  - 1
DO  - 10.23880/hij-16000230
ER  -